Exercise Intensity, Duration Can Affect CKD Risk in Obesity, Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Feb. 7, 2024 -- For adults with overweight/obesity and type 2 diabetes (T2D), longer duration of moderate-to-vigorous physical activity (MVPA) and increases in MVPA are associated with a reduced risk for progression to chronic kidney disease (CKD), according to a study published online Feb. 6 in the British Journal of Sports Medicine.
Mengyi Liu, from Nanfang Hospital in Guangzhou, China, and colleagues examined the long-term association of objectively measured MVPA and its longitudinal changes with progression to CKD in patients with T2D and overweight/obesity in a study including 1,746 participants. MVPA was measured at baseline and years 1, 4, and 8.
In total, 567 participants experienced progression to CKD during a median follow-up of 12.0 years. The researchers observed a linear inverse association of cumulative average total MVPA and MVPA accumulated in bouts of ≥10 minutes with progression to CKD (per 100 minutes/week higher amount: hazard ratios, 0.91 and 0.81, respectively). From baseline to year 4, an increase in total MVPA (fourth quartile; ≥63.2 minutes/week) was associated with a reduced risk for progression to CKD compared with the largest reduction in MVPA (<−198.3 minutes/week; hazard ratio, 0.67).
"Our study has important public health implications because it suggests that maintaining a high level of MVPA, regardless of length of the bout, may have renal benefit for adults with overweight/obesity and T2D, especially for individuals who are unwilling or unable to engage in PA bouts that are ≥10min in duration," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
American Diabetes Association, June 21-24
The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.